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OBJECTIVES: Considerable evidence of the positive impact of
pharmaceutical care services on patient’s HRQoL outcomes has
been reported. However, the implementation of HRQoL assess-
ment in routine pharmaceutical care has been limited. This study
aimed to assess the relevance of and challenges in the applica-
tion of HRQoL evaluation in the provision of pharmaceutical
care. METHODS: A self-administered survey of pharmacist was
conducted during a regional continuing education program in
New York metropolitan area. 83 pharmacists working mainly in
community setting participated in the study. RESULTS: Major-
ity of the respondents were male (81.9%), with extended (>16
years) practice experience (65.1%). More than 78.3% of respon-
dents indicated that HRQoL measures could be a useful tool to
assess patient’s health status. 55% of the respondents agreed that
positive results of HRQoL evaluations could help in obtaining
reimbursement for pharmaceutical care services. However, about
70% reported no familiarity with instruments such as SF-36/12,
EuroQOL, or FACT. Respondents rated clinical activities such
as patient outcomes evaluation and designing a therapeutic mon-
itoring plan as less important in the provision of pharmaceuti-
cal care compared to conventional activities (p < 0.05). Those
who reported better understanding about pharmaceutical care
tend to report greater knowledge regarding HRQoL outcomes
assessment. (p < 0.05) More than half reported difﬁculty in
choosing appropriate HRQoL instruments (56.6%) and chal-
lenges in interpreting HRQoL results (54.5%) as major barriers.
About 84.6% of the respondents indicated willingness to learn
more about HRQoL assessment to address such issues. CON-
CLUSIONS: Study respondents recognized the positive implica-
tions of HRQoL evaluations in practice. Incorporating HRQoL
measures in practice could facilitate better understanding of the
focus of pharmaceutical care among practitioners. However,
further training and education is required by a pharmacist to
implement HRQoL evaluation. Further research to include the
perception of pharmacists from different practice settings and
recent PharmD graduates is warranted.
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Patient empowerment has become a hot topic in academic med-
icine in recent years, however, most measures of empowerment
are disease speciﬁc, and often focus a particular issue such as
communication. There is a real need to develop measure of
patient empowerment that is both holistic and can be applied to
a general population. OBJECTIVES: To identify a holistic and
grounded conceptual model of empowerment that can serve as
a foundation for the development of a scale to measure patient
empowerment in the general community. METHODS: An exten-
sive literature review was used to review all MEDLINE articles
on empowerment over the past 20 years in order to: 1) deﬁne
what patient empowerment is and how it has been used in liter-
ature, and 2) what factors deﬁne patient empowerment. Based
on the results of this review, a draft conceptual model was devel-
oped and validated by a purposively selected group of experts
selected from a range of professional backgrounds in medicine.
RESULTS: In total 20 experts from 6 different countries 
participated, who suggested a range of improvements on the 
conceptual model. They also suggested a number of methods to
both measure preference and identify if patient, in fact, had a
preference for being empowered. Our study found that patient
empowerment can be measured over eight domains, categorized
into two main groups: human capital (knowledge; health 
status/outcomes; literacy; and ownership and responsibility) 
and health care system resources (access; advocacy; joint deci-
sion making and capacity and willingness to engage patients).
CONCLUSIONS: This paper demonstrates that patient empow-
erment is indeed multi-faceted. Future research will focus on
developing a scale to measure patient empowerment and to
determine whether patients have preferences to be empowered.
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OBJECTIVES: Policy makers and Medicaid administrators often
attempt to replicate cost containment strategies that have
worked in apparently similar states. Such measures result in
varied degrees of success owing possibly to not-so-obvious dif-
ferences between the states’ characteristics and determinants of
prescription drug expenditure. This study attempts to identify
homogenous groups (or clusters) of state Medicaid programs
based on variables that describe such characteristics, drug expen-
ditures and their determinants. METHODS: Variables were iden-
tiﬁed following Andersen’s Behavioral Model for Health Services
Utilization. Latest available data (2002) were obtained for the
above variables from public data sources for 48 fee-for-service
state Medicaid programs. Hierarchical Cluster Analysis tech-
nique was employed to identify optimum number of homoge-
neous groups of states by minimizing within-group variation and
maximizing between-group variation. Optimum number of 
clusters was identiﬁed based on the values of the R-squared
(RSQ), cubic clustering criterion (CCC), and pseudo F (PSF) sta-
tistics. Following identiﬁcation of optimum number of clusters,
cluster memberships were assigned and variables that deﬁned
cluster characteristics were identiﬁed. RESULTS: The ﬁrst step
identiﬁed seven clusters to appropriately classify the 48 state
Medicaid programs; RSQ = 68.6%, CCC = 2.0, and PSF = 14.9.
The second step assigned cluster memberships ranging from 2 
to 15 member states in a cluster. Key variables which described
the differences in cluster characteristics were: poverty levels 
(p = 0.024), access to primary care (p = 0.000), access to 
hospitals (p = 0.025), Federal matching for state drug expendi-
ture (p = 0.044), budgetary support for healthcare (p = 0.000),
drug expenditures (p = 0.043), and medical services expenditures
(p = 0.000). CONCLUSIONS: Identiﬁed clusters and their 
membership were not restricted to the commonly considered 
criteria of geographic proximity, socioeconomic characteristics,
or program expenditure levels. Hence, knowledge of these
groups, their membership, and the key variables that character-
ize them can further inform decision-making resulting in 
implementation of more cost-effective policy measures for 
Medicaid.
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